Key Metrics
CiteScore 

5.9
Eigenfactor 

0.001 - 0.005
H-Index 

57
Impact Factor 

< 5
SJR 

Q2Pharmacology (medical)

SNIP 

1.15
Recommended pre-submission checks
Powered by 

Topics Covered on American Journal of Cardiovascular Drugs
American Journal of Cardiovascular Drugs Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in American Journal of Cardiovascular Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in American Journal of Cardiovascular Drugs
Antihypertensive Efficacy and Safety of Angiotensin Receptor Blockers (ARBs) with and without Inverse Agonism: A Systematic Review and Network Meta-analysis.
- 8 Aug 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Adherence and Healthcare Costs Associated with Single-vs Free-Pill Combination of Perindopril-Based Antihypertensive Medications: An 11-Year Follow-Up, Real-World Evidence.
- 7 Aug 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
When Methods Matter: An Umbrella Review of Lorundrostat and the Impact of Analytical Decisions on Reported Blood Pressure and Safety Outcomes.
- 23 Jul 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Aspirin Versus Clopidogrel as Single Antiplatelet Therapy After TAVI: A Propensity Score-Matched, Retrospective Analysis.
- 21 Jul 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes.
- 17 Jul 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Food Effects on the Pharmacokinetics of Single Dose and Steady-State Ralinepag, a Novel Oral Prostacyclin Agonist, in Healthy Volunteers.
- 16 Jul 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Antihypertensive Efficacy and Safety of Angiotensin Receptor Blockers (ARBs) with and without Inverse Agonism: A Systematic Review and Network Meta-analysis.
- 8 Aug 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Adherence and Healthcare Costs Associated with Single-vs Free-Pill Combination of Perindopril-Based Antihypertensive Medications: An 11-Year Follow-Up, Real-World Evidence.
- 7 Aug 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
When Methods Matter: An Umbrella Review of Lorundrostat and the Impact of Analytical Decisions on Reported Blood Pressure and Safety Outcomes.
- 23 Jul 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Aspirin Versus Clopidogrel as Single Antiplatelet Therapy After TAVI: A Propensity Score-Matched, Retrospective Analysis.
- 21 Jul 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes.
- 17 Jul 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Food Effects on the Pharmacokinetics of Single Dose and Steady-State Ralinepag, a Novel Oral Prostacyclin Agonist, in Healthy Volunteers.
- 16 Jul 2026
- American journal of cardiovascular drugs : drugs, devices, and other interventions